Matrixyl vs Melanotan I
A detailed comparison to help you understand the differences and choose the right peptide for your research goals.
Matrixyl
Matrixyl (Palmitoyl Pentapeptide-4) is a signal peptide that stimulates collagen and extracellular matrix production. It is one of the most well-studied anti-aging peptides with proven efficacy for wrinkle reduction.
Full details →Melanotan I
Melanotan I (afamelanotide) is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH). It is FDA-approved as Scenesse for erythropoietic protoporphyria (EPP), a rare genetic disorder causing severe sun sensitivity.
Full details →Side-by-Side Comparison
| Aspect | Matrixyl | Melanotan I |
|---|---|---|
| Dose Range | 500 mcg–2 mg | 250 mcg–500 mcg |
| Frequency | 2x daily | 1x daily |
| Cycle Length | 4–12 weeks | 1–4 weeks |
| Route | topical | subcutaneous |
| Mechanism | Mimics collagen breakdown fragments, triggering fibroblasts to produce new collagen, elastin, and other matrix components. Essentially tricks skin into repair mode without actual damage. | Binds to melanocortin 1 receptors (MC1R) on melanocytes, stimulating eumelanin production. This increases skin pigmentation and provides photoprotection without UV exposure. |
| Typical Dosage | Topical: 2-8% concentration in serums and creams. Matrixyl 3000 combines it with Palmitoyl Tetrapeptide-7 for enhanced effects. | Clinical: 16mg implant every 2 months. Research protocols for tanning typically use 0.5-1mg daily for loading, then maintenance dosing. |
| Administration | Topical application 1-2 times daily. Can be combined with other actives like retinol, vitamin C, and other peptides. | FDA-approved form is a subcutaneous implant. Research use involves subcutaneous injection. Often combined with minimal UV exposure to enhance results. |
| Side Effects | Very well-tolerated. Rare mild irritation. Suitable for sensitive skin types. | Nausea (especially initially), facial flushing, fatigue, headache, and darkening of existing moles or freckles. |
| Best For |
What They Have in Common
Matrixyl, Melanotan I are both commonly used for:
Key Differences
Unique to Matrixyl:
Which Has Stronger Evidence?
| Goal | Matrixyl | Melanotan I |
|---|---|---|
| Skin Health & Aesthetics | high | high |
Key Studies
Matrixyl
- Matrixyl Patch vs Matrixyl Cream: A Comparative In Vivo Investigation of Matrixyl (MTI) Effect on Wound Healing.
ACS omega, 2022
Melanotan I
- Use of melanotan I and II in the general population.
BMJ (Clinical research ed.), 2009
- Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, Melanotan-I.
Pharmaceutical research, 2000
- Discovery and development of novel melanogenic drugs. Melanotan-I and -II.
Pharmaceutical biotechnology, 1998
Ready to Learn More?
Looking for trusted sources?